Tel Aviv indexes closed up 1% after violent swings dictated by the mood of the news emanating from the
Sharm el-Sheikh emergency summit
Investors spent the day reacting sharply to developing events at the meeting between Middle East leaders,
and leading diplomats from the
, and also to news of sporadic fighting between Israelis and Palestinians. Ultimately Israeli stocks ended with gains, boosted by word of a compromise and a joint statement condemning violence and the need to build mechanisms to assure that the turmoil would not resume.
Tel Aviv Stock Exchange
session opened with sharp losses, based on assessments that the summit between Israel and the Palestinians, hosted by Egypt, would achieve nothing more than explosions of flaring tempers. Initial assessments had the summit ending at 10 a.m. local time, probably in a flurry of mutual recrimination. Before noon Tel Aviv's leading indices had dived 4%.
But when Clinton announced that the summit had been a success and outlined its conclusions, investor ears pricked up and Israeli stocks picked up, shooting up 6% from a loss of 3.5% to a gain of 2.5% within moments. The steep gain gradually decreased to about 1% shortly before closing.
The session could certainly be characterized a nervous one, on high turnover, as the mood swung with the news from Egypt.
index ended with a gain of 0.9%, or 498.4 points, and the
index rose 0.7% to 493.5 points. The
index of technology stocks edged up by 0.4%. Total turnover was high, valued at 529 million shekels, or $128 million.
Bank stocks were weak almost throughout the session, but managed to rally before closing.
inched up a meager 0.1% on the session's biggest turnover of 69 million shekels ($16.7 million) after spending the session firmly entrenched in the red.
added 1.9% on 55.5 million shekel ($13.4 million) turnover.
edged up 0.3% on 5.7 million shekels ($1.38 million).
closed up 3% on 51 million shekels ($12.3 million) changing hands. Monday Teva won a buy recommendation from the
First International Bank of Israel
, which set a price target 25% above the market. Teva opened the day with losses together with its brother blue-chips, but leapt on the good word from Sharm and Clinton. Today
concurred, calling it a buy opportunity and setting a target of $80.
TheMarker is a leading source for technology and business news information in Israel. The site is a venture backed by the Israeli daily Haaretz and TheStreet.com. For more stories from TheMarker, go to http://www.themarker.com/eng/